Aniline → HCID 58875326, compound
Reaction equation
[CH:1]([C:3]1[CH:22]=[CH:21][C:6]([CH2:7][NH:8][C:9]([C:11]2[CH:12]=[C:13]3[C:18](=[CH:19][CH:20]=2)[N:17]=[CH:16][CH:15]=[CH:14]3)=[O:10])=[CH:5][CH:4]=1)=O.[C:23]1([NH2:29])[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1>>[C:23]1([NH:29][CH2:1][C:3]2[CH:22]=[CH:21][C:6]([CH2:7][NH:8][C:9]([C:11]3[CH:12]=[C:13]4[C:18](=[CH:19][CH:20]=3)[N:17]=[CH:16][CH:15]=[CH:14]4)=[O:10])=[CH:5][CH:4]=2)[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1Participants
3
Procedure
The title compound (13.8 mg) was obtained according to an analogous method to Example E-26 using quinoline-6-carboxylic acid 4-formyl-benzylamide described in Preparation Example E+-6 (50 mg, 0.172 mmol) instead of formalin, and phenylamine (31 μl, 10.34 mmol) instead of quinoline-6-carboxylic acid 4-benzyl amino-benzylamide. Trifluoroacetic acid salt of the title compound was obtained by reverse phase high performance liquid chromatography (acetonitrile-water mobile phase (containing 0.1% trifluoroacetic acid) was used).
Sources & evidence
- ORD record
- ord-07dc8ba828b243ebab42c972debbdc3b
- Source dataset
- uspto-grants-2011_04
- Patent number
- US07932272B2
Reaction notes
Loading…